日本の血管外科と血管内手術市場-2024～2031年

概要

日本の血管外科と血管内手術市場は、2023年に1億2,250万米ドルに達し、2031年には2億2,400万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは7.9%で成長する見込みです。

血管外科は、動脈、静脈、リンパ管を含む血管系に影響を及ぼす疾患や状態の診断と治療に重点を置く医療専門分野です。これらの構造は、血液やリンパを全身に循環させるために不可欠です。血管外科医は、血流を回復させたり、血管の詰まりを取り除いたりするために、従来の開腹手術と低侵襲手術の両方を行います。血管内治療法は、小さな穿刺や切開で血管の状態を治療する低侵襲技術です。これらの治療法では、カテーテルやワイヤーなどの器具を血管に通して、開腹手術を必要としない治療を行う。

日本における血管外科と血管内手術市場の需要は、人口の高齢化、血管疾患の有病率の上昇、低侵襲技術の進歩などの要因によって、着実に伸びています。例えば、日本血管外科学会によると、動脈瘤治療の分野では、総腸骨動脈瘤を含む腹部大動脈瘤（AAA）20,160例が登録され、61.6％が血管内動脈瘤修復術（EVAR）で治療されています。AAA症例のうち、1,794例（8.9％）が破裂AAAとして登録されています。

市場力学：

促進要因と抑制要因

高齢化人口の増加

高齢化率の上昇が日本の血管外科と血管内手術市場を大きく牽引しており、予測期間中も市場を牽引していくとみられます。高齢者の割合が増加し続ける中、高齢者に多い血管疾患の有病率が増加しています。この人口動態の変化は、従来の血管手術と低侵襲血管内治療の両方の需要に大きな影響を与えています。

高齢になるにつれて、末梢動脈疾患（PAD）、大動脈瘤、静脈瘤、脳卒中など、血管インターベンションを必要とすることが多い疾患にかかりやすくなります。例えば、世界経済フォーラムによれば、日本はますます高齢化が進んでいます。今や国民の10人に1人以上が80歳以上です。人口のほぼ3分の1が65歳以上であり、その数は推定3,623万人です。脳卒中リスクは、特に高齢者に多い血管疾患である頸動脈疾患により、加齢とともに上昇します。

血管外科と血管内手術に伴う高コスト

血管外科と血管内手術に伴う高コストは、予測期間中の市場成長の妨げになると予想されます。ステント、グラフト、コイルなどの血管内デバイスは、製造や使用にコストがかかります。

特殊なグラフトや画像機器を必要とする血管内動脈瘤修復術（EVAR）の費用は、従来の手術よりも大幅に高くなる可能性があります。例えば、オックスフォード・アカデミーによると、EVARの平均医療費は患者一人当たり日本円で35,2000円でした。

さらに、国立衛生研究所が実施した研究によると、開腹手術による修復（OR）とEVARの平均コストは、診断手順組み合わせ（DPC）がそれぞれ632,370円対490,050円で、有意差があり、麻酔がそれぞれ123,540円対86,220円、材料がそれぞれ257,770円対2,113,280円でした。したがって、平均総費用は開腹手術が1,825,830円、EVARが3,159,270円でした。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 高齢化人口の増加
    • 低侵襲技術の進歩
  • 抑制要因
    • 血管外科と血管内手術に伴う高額な費用
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 手順別

• 動脈瘤の修復
• バイパス手術
• 頸動脈形成術とステント留置術
• 血管内修復
• その他

第7章 製品タイプ別

• ステントとステントグラフト
• 血管内ツール
• はさみと鉗子
• ニードルホルダー
• その他

第8章 エンドユーザー別

• 病院
• 外科センター
• 学術調査機関
• その他

第9章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第10章 企業プロファイル

• Terumo Corporation
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Olympus Corporation
• FUJIFILM Holdings Corporation
• Mizuho Medical Co., Ltd.
• Nipro Corporation
• Shimadzu Corporation
• SB-KAWASUMI LABORATORIES, INC.
• ASAHI INTECC CO., LTD.
• Medtronic plc
• Boston Scientific Corporation

第11章 付録

Overview

The Japan vascular surgery and endovascular procedures market reached US$ 122.5 million in 2023 and is expected to reach US$ 224.0 million by 2031, growing at a CAGR of 7.9% during the forecast period 2024-2031.

Vascular surgery is a medical specialty focused on diagnosing and treating diseases and conditions affecting the vascular system, which includes arteries, veins, and lymphatic vessels. These structures are essential for circulating blood and lymph throughout the body. Vascular surgeons perform both traditional open surgeries and minimally invasive procedures to restore blood flow or remove blockages in the vessels. Endovascular procedures are minimally invasive techniques used to treat vascular conditions through small punctures or incisions. These procedures involve the use of catheters, wires, and other devices guided through blood vessels to perform treatments without the need for open surgery.

The market demand for vascular surgery and endovascular procedures in Japan has been growing steadily, driven by factors such as the aging population, rising prevalence of vascular diseases, and advancements in minimally invasive technologies. For instance, according to the Japanese Society for Vascular Surgery, in the field of aneurysm treatment, 20,160 cases of abdominal aortic aneurysm (AAA) including common iliac aneurysms were registered, and 61.6% were treated by endovascular aneurysm repair (EVAR). Among AAA cases, 1,794 (8.9%) cases were registered as ruptured AAA.

Market Dynamics: Drivers & Restraints

Rising aging population

The rising aging population is significantly driving the Japan vascular surgery and endovascular procedures market and is expected to drive the market over the forecast period. As the proportion of elderly people continues to rise, there is an increased prevalence of vascular diseases, which are more common among older individuals. This demographic shift is significantly impacting the demand for both traditional vascular surgery and minimally invasive endovascular treatments.

As people age, they are more susceptible to conditions like peripheral arterial disease (PAD), aortic aneurysms, varicose veins, and stroke all of which often require vascular interventions. For instance, according to the World Economic Forum, Japan is getting ever greyer. More than 1 in 10 people in the country are now aged 80 or older. Almost a third of its population is over 65 - an estimated 36.23 million. Stroke risk rises with age, particularly due to carotid artery disease, which is a common vascular condition in older people

High cost associated with vascular surgery and endovascular procedures

The high cost associated with vascular surgery and endovascular procedures is expected to hamper the growth of the market over the forecast period. Endovascular Devices such as stents, grafts, and coils are expensive to manufacture and use.

The cost of Endovascular Aneurysm Repair (EVAR), which requires specialized grafts and imaging equipment, can be significantly higher than traditional surgery. For instance, according to the Oxford Academy, the average medical cost for EVAR was 35,2000 Japanese Yen per patient.

Additionally, according to a study conducted by the National Institute of Health, the mean costs for open surgical repair (OR) versus EVAR were as follows, Diagnosis Procedure Combination (DPC) ¥632,370 versus ¥490,050, respectively, which was significant; anesthesia, ¥123,540 versus ¥86,220, respectively and materials, ¥257,770 versus ¥2,113,280, respectively. Thus, the mean total cost was ¥1,825,830 versus ¥3,159,270 for open repair and EVAR, respectively.

Segment Analysis

The Japan vascular surgery and endovascular procedures market is segmented based on procedure, product type and end-user.

Procedure:

The endovascular repair segment is expected to dominate the Japan vascular surgery and endovascular procedures market share

The endovascular repair segment holds a major portion of the Japan vascular surgery and endovascular procedures market share and is expected to continue to hold a significant portion of the market share over the forecast period. Endovascular repair involves the use of minimally invasive techniques to treat vascular conditions such as abdominal aortic aneurysms (AAA) and peripheral arterial disease (PAD). These procedures use small incisions or punctures, making them far less invasive than traditional open surgery.

The demand for EVAR has surged in Japan as patients prefer less invasive procedures that offer faster recovery times and shorter hospital stays. For instance, according to the J-Stage, as of 2020, EVAR accounted for over 60% of AAA cases in Japan, indicating its dominance in the treatment of aneurysms.

Endovascular repair has benefited from technological innovations in medical devices, imaging, and procedural techniques. The introduction of advanced stents, drug-eluting balloons and robotic-assisted navigation has made endovascular repair even more efficient, safe, and accessible. This has contributed to the widespread adoption of these procedures across Japan.

Competitive Landscape

The major Japan players in the vascular surgery and endovascular procedures market include Terumo Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, Mizuho Medical Co., Ltd., Nipro Corporation, Shimadzu Corporation, SB-KAWASUMI LABORATORIES, INC., ASAHI INTECC CO., LTD., Medtronic plc, Boston Scientific Corporation and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan vascular surgery and endovascular procedures market report would provide approximately 39 tables, 31 figures and 197 pages.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Procedure
• 3.2. Snippet by Product Type
• 3.3. Snippet by End-User

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Aging Population
    • 4.1.1.2. Advancements in Minimally Invasive Techniques
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost Associated with Vascular Surgery and Endovascular Procedures
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Procedure

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
  • 6.1.2. Market Attractiveness Index, By Procedure
• 6.2. Aneurysm Repair*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Bypass Surgery
• 6.4. Carotid Angioplasty and Stenting
• 6.5. Endovascular Repair
• 6.6. Others

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Stents and Stent Grafts*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Endovascular Tools
• 7.4. Scissors and Forceps
• 7.5. Needle Holders
• 7.6. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Hospitals
• 8.4. Surgical Centers
• 8.5. Academic and Research Institutions
• 8.6. Others

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

• 10.1. Terumo Corporation*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio and Description
  • 10.1.3. Financial Overview
  • 10.1.4. Key Developments
• 10.2. Olympus Corporation
• 10.3. FUJIFILM Holdings Corporation
• 10.4. Mizuho Medical Co., Ltd.
• 10.5. Nipro Corporation
• 10.6. Shimadzu Corporation
• 10.7. SB-KAWASUMI LABORATORIES, INC.
• 10.8. ASAHI INTECC CO., LTD.
• 10.9. Medtronic plc
• 10.10. Boston Scientific Corporation

LIST NOT EXHAUSTIVE

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us